JP2020533321A - クロロプロカインの表面麻酔製剤 - Google Patents

クロロプロカインの表面麻酔製剤 Download PDF

Info

Publication number
JP2020533321A
JP2020533321A JP2020513886A JP2020513886A JP2020533321A JP 2020533321 A JP2020533321 A JP 2020533321A JP 2020513886 A JP2020513886 A JP 2020513886A JP 2020513886 A JP2020513886 A JP 2020513886A JP 2020533321 A JP2020533321 A JP 2020533321A
Authority
JP
Japan
Prior art keywords
preparation according
chloroprocaine
anesthesia
weight
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020513886A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533321A5 (https=
Inventor
ミティディエーリ アウグスト
ミティディエーリ アウグスト
ドナーティ エリザベッタ
ドナーティ エリザベッタ
ビアンキ クラーラ
ビアンキ クラーラ
Original Assignee
シンテティカ ソシエテ アノニム
シンテティカ ソシエテ アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シンテティカ ソシエテ アノニム, シンテティカ ソシエテ アノニム filed Critical シンテティカ ソシエテ アノニム
Publication of JP2020533321A publication Critical patent/JP2020533321A/ja
Publication of JP2020533321A5 publication Critical patent/JP2020533321A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2020513886A 2017-09-15 2018-09-14 クロロプロカインの表面麻酔製剤 Pending JP2020533321A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762559220P 2017-09-15 2017-09-15
US62/559,220 2017-09-15
PCT/IB2018/057073 WO2019053657A1 (en) 2017-09-15 2018-09-14 TOPICAL FORMULATIONS OF CHLOROPROCAINE

Publications (2)

Publication Number Publication Date
JP2020533321A true JP2020533321A (ja) 2020-11-19
JP2020533321A5 JP2020533321A5 (https=) 2021-11-04

Family

ID=63713967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020513886A Pending JP2020533321A (ja) 2017-09-15 2018-09-14 クロロプロカインの表面麻酔製剤

Country Status (22)

Country Link
US (3) US10792271B2 (https=)
EP (1) EP3681473A1 (https=)
JP (1) JP2020533321A (https=)
KR (1) KR102759903B1 (https=)
CN (1) CN111163756B (https=)
AU (1) AU2018332212B2 (https=)
CA (1) CA3070336C (https=)
CL (1) CL2020000665A1 (https=)
CO (1) CO2020002985A2 (https=)
CR (1) CR20200133A (https=)
CU (1) CU20200019A7 (https=)
EA (1) EA202090735A1 (https=)
EC (1) ECSP20022313A (https=)
IL (1) IL273213B2 (https=)
JO (1) JOP20200010A1 (https=)
MA (1) MA50241A (https=)
MX (1) MX2020002898A (https=)
PE (1) PE20201281A1 (https=)
PH (1) PH12020550029A1 (https=)
SG (1) SG11202000992RA (https=)
WO (1) WO2019053657A1 (https=)
ZA (1) ZA202000601B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202139993A (zh) * 2020-03-16 2021-11-01 瑞士商辛鐵堤卡公司 具有經改良之功能性的眼用氯普魯卡因(chloroprocaine)凝膠

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004123634A (ja) * 2002-10-03 2004-04-22 Lion Corp 眼科用組成物
US20050137177A1 (en) * 2003-12-18 2005-06-23 Shafer Steven L. Ester combination local anesthetic
JP2006513224A (ja) * 2002-12-20 2006-04-20 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ エステル局所麻酔薬の組み合わせ
CN103405576A (zh) * 2013-08-23 2013-11-27 何学忠 一种治疗由焊接强光辐射引起的眼部疾病的滴眼液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000050B1 (ko) * 1990-08-29 1993-01-06 브리스톨-마이어즈 스퀴브 컴페니 항균제 겔 배합물
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
EA200701131A1 (ru) * 2004-11-24 2007-12-28 Алгоркс Фармасьютикалз, Инк. Гелеобразная препаративная форма капсаициноида и способы её применения
ITMI20051633A1 (it) 2005-09-06 2007-03-07 Sint Sa Nuovo uso di una composizione comprendente cloroprocaina hcl nuova composizione comprendente cloroprocaina hcl e metodo per la sua fabbricazione
ITMI20122120A1 (it) * 2012-12-12 2014-06-13 Sint Sa Composizione farmaceutica a base di cloroprocaina per la somministrazione intratecale ripetuta

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004123634A (ja) * 2002-10-03 2004-04-22 Lion Corp 眼科用組成物
JP2006513224A (ja) * 2002-12-20 2006-04-20 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ エステル局所麻酔薬の組み合わせ
US20050137177A1 (en) * 2003-12-18 2005-06-23 Shafer Steven L. Ester combination local anesthetic
CN103405576A (zh) * 2013-08-23 2013-11-27 何学忠 一种治疗由焊接强光辐射引起的眼部疾病的滴眼液

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MCLURE HA ET AL., MINERVA ANESTESIOLOGICA, vol. 71, no. 3, JPN6023020133, 2005, pages 59 - 74, ISSN: 0005063857 *
MONICA GARCIA-VALLDECABRES: "pH Stability of ophthalmic solutions", OPTOMETRY, vol. Vol.75, Issue 3, JPN6022039844, 2004, pages 161 - 168, ISSN: 0005063856 *

Also Published As

Publication number Publication date
EP3681473A1 (en) 2020-07-22
IL273213B2 (en) 2025-06-01
IL273213B1 (en) 2025-02-01
KR20200053476A (ko) 2020-05-18
AU2018332212A1 (en) 2020-02-27
MX2020002898A (es) 2020-11-06
CA3070336C (en) 2022-08-23
CU20200019A7 (es) 2020-11-30
WO2019053657A1 (en) 2019-03-21
IL273213A (en) 2020-04-30
AU2018332212B2 (en) 2023-03-16
KR102759903B1 (ko) 2025-01-23
US11969403B2 (en) 2024-04-30
EA202090735A1 (ru) 2020-06-22
US20190083446A1 (en) 2019-03-21
US10792271B2 (en) 2020-10-06
BR112020003095A2 (pt) 2020-08-25
CL2020000665A1 (es) 2020-09-21
SG11202000992RA (en) 2020-03-30
JOP20200010A1 (ar) 2020-01-22
CA3070336A1 (en) 2019-03-21
CN111163756A (zh) 2020-05-15
ZA202000601B (en) 2021-02-24
PH12020550029A1 (en) 2021-02-08
CO2020002985A2 (es) 2020-05-29
ECSP20022313A (es) 2020-07-31
CN111163756B (zh) 2022-04-15
US20200390738A1 (en) 2020-12-17
US20240216323A1 (en) 2024-07-04
MA50241A (fr) 2020-07-22
CR20200133A (es) 2020-05-09
PE20201281A1 (es) 2020-11-24

Similar Documents

Publication Publication Date Title
JP5972862B2 (ja) 熱ゲル化麻酔組成物
RU2297831C2 (ru) Офтальмологический гель пирензепина
ES2221127T3 (es) Uso de acitromicina en el tratamiento topico de infecciones oculares.
TW202122094A (zh) 含有迪夸弗索(diquafosol)或其鹽、及聚乙烯吡咯烷酮之水性眼科用組合物
JP7770030B2 (ja) 機能性の改善を有する眼科用クロロプロカインゲル
US20240216323A1 (en) Topical formulations of chloroprocaine and methods of using same
AU2014216273A1 (en) Topical ocular analgesic agents
OA19516A (en) Topical formulations of Chloroprocaine.
EA044204B1 (ru) Офтальмологический состав хлорпрокаина для местного применения
CN101677943B (zh) 使用苯甲醇的多剂量浓缩艾司洛尔
BR112020003095B1 (pt) Formulações tópicas de cloroprocaína e métodos de utilização dos mesmos
ES2983432T3 (es) Composición para el tratamiento y/o la prevención de la vestibulodinia
RU2837317C1 (ru) Глазной термочувствительный in situ гель лидокаина и способ его получения
JP2020533321A5 (https=)
RU2323721C2 (ru) Местноанестезирующее и антисептическое средство
HK40035093B (zh) 用於治疗手术後疼痛的药物组合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210913

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210913

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220822

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220920

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230523